BALTIMORE, MD  – PathSensors Inc, a Baltimore biotechnology company, announced today that they are developing a CANARY biosensor to detect the Novel SARS Coronavirus (SARS-CoV-2), the causal agent for the coronavirus disease COVID–19. The biosensor will be available for research purposes in May 2020 and validation data on the new SARS-CoV-2 product will be available […]